Abstract
Background: Extraneural metastases are relatively rare manifestations of medulloblastoma. Case presentation: We present the case of a young boy with group three MYCN-amplified medulloblastoma. He received multimodal chemotherapy consisting of gross total resection followed by postoperative craniospinal radiation and adjuvant chemotherapy. The patient developed extraneural metastases 4 months after the end of therapy. Literature review identifies the poor prognosis of MYCN-amplified medulloblastomas as well as extraneural metastases; we review the current limitations and future directions of medulloblastoma treatment options. Conclusion: To the best of our knowledge, this is the first molecularly characterized report of extraneural metastases of medulloblastoma in a child.
Author supplied keywords
Cite
CITATION STYLE
Mobark, N. A., Al-Harbi, M., Mosleh, O., Santagata, S., Snuderl, M., & Abedalthagafi, M. (2018). A case of molecularly profiled extraneural medulloblastoma metastases in a child. BMC Medical Genetics, 19(1). https://doi.org/10.1186/s12881-018-0526-8
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.